Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...

That challenge, of finding or building good, useable data sets, is also one of the biggest differentiators in an increasingly ...

Biogen has emerged as a potential front-runner at the Cannes Lions International Festival of Creativity, snagging four spots ...

The president wants foreign countries to pay more for drugs made in the US to help Big Pharma firms make more money abroad.

During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...

The recent experience of Chinese biotech companies in developing their own drug candidates and inking deals with larger ...

Amid a spate of high-profile investments in U.S. pharmaceutical production, two contract manufacturers are getting in on the ...

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.